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Abstract The disulfide bridge closed cyclic peptide correspond- 
ing to the whole Consensus V3 loop of the envelope protein gpl20 
of HIV-1 was examined by proton 2D-NMR spectroscopy in 
water and in a 20% trifluoroethanol/water solution. In water, 
NOE data support a B-turn conformation for the central conser- 
vative GPGR region and point towards partial formation of a 
helix in the C-terminal part. Upon addition of trifluoroethanol, 
a C-terminal helix is formed. This is evidenced by NOE data, 
a-proton chemical shift changes and changes in the JNo vicinal 
coupling constants. The C-terminal helix is amphipathic and also 
occurs in other examined strains. It could therefore be an impor- 
tant feature for the functioning of the V3 loop. 
Key words: NMR; Consensus equence V3 loop; 
Conformation in solution; Amphipathic helix; gpl20; HIV-1 
I. Introduction 
The crucial proteins involved in the first steps of infection of 
CD4-positive cells by the human immunodeficiency virus type 
I (HIV-1) are the HIV-1 envelope glycoprotein gpl20 and its 
associated transmembrane glycoprotein gp41 [1,2]. Binding of 
gp 120 tp CD4 induces tructural changes in gpl20 [3,4], thereby 
disrupting the heterodimeric gpl20-gp41 complex and expos- 
ing fusogenic domains at the N-terminal region of gp41 [5]. This 
ultimately results in the fusion of the lipid bilayers of the viral 
envelope and the target cellular membrane [6,7]. The third 
variable region (V3) of gpl20 is also involved in this fusion step 
[8,9], but its specific role in cell penetration has not yet been 
fully clarified. 
The V3 region is a surface accessible oop formed by a disul- 
fide bridge between two invariant cysteines at positions 303 and 
338 ofgpl20 [10] and is the part of HIV-1 which is most subject 
to antibody response [11,12]. Antibodies directed towards the 
V3 loop do not affect gpl20-CD4 binding, but do prevent he 
subsequent cell infection [13]. The amino acid sequence of V3 
loops is highly variable among different isolates, especially in 
the regions flanking the highly conserved central part [14]. This 
variability ensures that most antibodies which are elicited 
against he V3 loop of one strain are not effective against V3 
loops of other strains. Antibodies directed against he highly 
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troscopy: TOCSY, total correlation spectroscopy. 
conserved central GPGR region, however, do respond to a 
range of HIV-1 strains [14-16]. Elucidating the structure of V3 
loops can thus provide insight in the importance of the central 
region. Determinants for viral tropism and syncytium inducing 
capacity are also situated within this loop [17-22]. Comparing 
the conformations preferred by the V3 loops of different strains 
could therefore point out important structural features associ- 
ated with viral tropism. 
Previous experimental work on the complete V3 loops of the 
MN [23,24], the Chang Mai [25] and the RF (Vranken et al., 
submitted) strains proved their respective central GPGX se- 
quence to prefer a/3-turn conformation, while the remainder 
of the loop was subject o considerable conformational verag- 
ing in water. The studies on the MN and RF V3 loops showed 
the C-terminal part to incline toward helical structures, espe- 
cially in trifluoroethanol (TFE)/water mixtures, while in the 
Chang Mai peptide two extended ]~-strand regions flanking the 
central turn were apparently present. 
The Consensus V3 loop sequence derived from 245 V3 loop 
sequences [14] corresponds to existing macrophagetropic 
strains (BALl, JRFL, LRCSF, ADA) [19]. For this Consensus 
sequence, a neural network approach predicted an N-terminal 
]~ strand followed by a type II B-turn (incorporating the con- 
served GPGR fragment), a second t-strand and finally a C- 
terminal c~-helix [14]. 
In the present paper we report the characterization f a 
disulfide-bridged peptide corresponding to the Consensus e- 
quence of the HIV-1 V3 loop in water solution and in 20% 
TFE/water mixture by two-dimensional proton nuclear mag- 
netic resonance. 
2. Materials and methods 
The disulfide bridge closed cyclic peptide corresponding tothe whole 
Consensus V3 loop of the envelope protein gpl20 of HIV-1 was pur- 
chased as the 'Universal' V3 loop of gpl20 from Neosystem Labora- 
toire (Strasbourg, France). The purity of the peptide was 93% by 
HPLC. An electrospray mass spectrum shows the peptide to have a 
molecular weight of 3895.3 Da, corresponding to the correct disulfide 
bridge closed peptide. The presence of the disulfide bridge in solution 
is confirmed by NOE contacts between sidechain protons of Cys t and 
Cys 35 (data not shown). 
2.1. Sample preparation 
The initial NMR sample was a 4.0 mM solution of the peptide in a 
mixture of 90% H20 and 10% D20 at a pH of 2.5. The solution was 
not buffered. Sodium 2,2-dimethyl-2-silapentane-5-sulfonate (DSS) 
was added as an internal chemical shift reference. The 20% v/v TFE/ 
water solution was obtained by adding the appropriate amount of 
deuterated TFE to the water sample. 
2.2. NMR measurements 
All proton NMR spectra were acquired on a Bruker AM-500 spec- 
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trometer. Two-dimensional NMR experiments performed on the water 
solution Consensus ample at 275 K were a magnitude COSY [26], a 
TOCSY (spin-lock time ZSL = 75 ms) [27], two NOESYs (mixing times 
rm = 300 and 150 ms) [28], a ROESY (Zsc = 150 ms) [29,30] and two 
CT-NOE spectra (rm = 300 ms, with constant time delay r~ set for 6.0 
and 7.9 Hz couplings) [31]. 
Spectra of the 20% TFE solution of Consensus were recorded at 
several temperatures. A TOCSY (rsc = 60 ms) and NOESY (rm = 300 
ms) were recorded at 280 K, a TOCSY (Vse = 60 ms), two NOESYs 
(% = 300 ms and Tm : 150 ms) and two CT-NOE spectra (rm = 300 ms, 
with constant time delay re set for 6.0 and 7.9 Hz couplings) at 290 K, 
and a TOCSY (rsc = 60 ms) at 300 K. The H~O peak was suppressed 
by selective irradiation during the 1.2 s relaxation delay [32,33]. The 
irradiation was continued uring the mixing time in the NOESY spec- 
tra. The spin-lock used in the TOCSY spectra, with a field strength of 
8.4 kHz, was an MLEV-17 sequence preceded by a 1.5 ms trim pulse. 
In the ROESY spectra continuous irradiation with a field strength of 
3.8 kHz was used for spin-locking. The spectra were acquired in the F2 
dimension with 2048 real data points and in FI with 512 t,-increments. 
Time proportional phase incrementation (TPPI) [34] was used for 
phase- sensitive acquisition. The data were processed on a Bruker X32 
workstation using the UXNMR program. A squared cosine window 
function was used in the F2 dimension, a ~r/3 shifted sine function in 
the F1 dimension. The Fourier-transformed spectra had 2k data points 
in both dimensions, giving a digital resolution of 3.4 Hz/pt. A polyno- 
mial baseline correction was performed in the F2 dimension. Spectral 
analysis was done manually on plotted spectra nd on a Silicon Graph- 
ics Crimson workstation with the program PRONTO [35]. 
3. Results 
3.1. Assignments 
The proton resonances were assigned according to the estab- 
lished sequential strategy [36] using 2D COSY and TOCSY 
spectra to recognize amino acid spin systems and 2D ROESY 
and NOESY spectra to identify sequential connectivities. Low 
chemical shift dispersion resulted in extensive overlap of the 
resonances in both water and TFE/water solutions. Additional 
problems due to line broadening were encountered in the 20% 
TFE spectrum, making the extraction of chemical shift values 
at 280 K and the extraction of NOE data at 290 K necessary. 
Table 1A shows the complete assignment of all protons with 
their chemical shift values as extracted from the 2D NOESY 
spectrum at 275 K in water. Table 1B shows the assignments 
as extracted from the 2D NOESY spectrum at 280 K in 20% 
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Fig. 1. Diagrams howing the sequential NOE connectivities and the 
NOE connectivities indicating secondary structure observed in the 
water (A) and the 20% v/v TFE/water (B) solutions of the Consensus 
V3 loop peptide. 
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Fig. 2. Diagrams howing the CT-NOE intensities of the NH resonance 
lines in F1 of the Consensus V3 loop peptide in water (A) and a 20% 
v/v TFE/water (B) solution. The CT-NOE spectra recorded had zero 
amplitude modulation for 6.0 and 7.9 Hz couplings. Negative intensity 
indicates a3JN, coupling lower than the value shown on the left, positive 
intensity indicates a 3JNa coupling higher than the value shown on the 
left. 
TFE. All observed sequential NOE connectivities (d~N(i,i+ 1), 
d~N(i,i+ 1) and dNN(i,i+ 1)) are summarized in Fig. 1A and B. 
Sequential NOE connectivities of the c~ protons of Arg 3 and 
Gly ]5 with the ~ protons of Pro 4 and Pro ]6, respectively, evi- 
dence that both Xxx-Pro amide bonds have the trans configura- 
tion in the major isomer. A few weak signals from a minor 
component could not be assigned unambiguously to a cis iso- 
mer. 
3.2. Conformation in water 
In water solution the peptide still exists as a mixture of 
conformations. This is experimentally evidenced by the back- 
bone and side chain chemical shift values, which closely ap- 
proach typical random coil values [37] (Fig. 3), and by the 
vicinal JN~ coupling constants observed via two CT-NOE spec- 
tra* (Fig. 2A), which range between 6.0 and 7.9 Hz for almost 
all residues. The values below 6.0 Hz for Ala j9 and Ala 33 are 
not unusual and have been measured before for alanine resi- 
dues in random coil peptides [37]. 
The observed NOE connectivities (Fig. 1A) also confirm the 
disordered state of the V3 Consensus peptide in water. The 
consistent presence of both strong d~N(i,i+ 1) and relatively 
strong dNN(i,i+ 1) NOEs indicates that the peptide samples a 
broad range of conformations. A series of consecutive NOE 
contacts that are diagnostic for regular secondary structures (a 
well-defined fl-sheet (long-range d~(i,j) or d~N(i,j) NOEs) or an 
ordered c~-helix (d~(i,i + 3), d~N(i,i + 3) and d~N(i,i + 4) NOEs)) 
could not be observed in the water solution. 
Although no regular secondary structure is present, the oc- 
currence of relatively strong dNN(i,i+ 1) NOEs throughout the 
V3 Consensus peptide, in combination with the presence of 
several D~y(i,i+2) contacts (Pro4-Asn 6, Gl fS-Gly 17, Pro ]6- 
Ar f  s, Thr2LGly 24, Gly24-Ile 26, Ile27-Asp 29 and Ile3°-Gln32) sug- 
gest that some segments have a preference for the ~ region of 
*In 2D CT-NOE spectra, only the chemical shift is t~-dependent, while 
the coupling constants, together with a constant time re, modulate the 
amplitude of the cross-peaks in FI. By choosing v~ properly one can 
accomplish that, for example, all couplings greater than 7 Hz generate 
positive cross peaks in F1, while couplings maller than 7 Hz generate 
negative cross-peaks in F1. This also means that unambiguous conclu- 
sions about the coupling a proton experiences can only be obtained 
from the amplitude if the proton experiences only one coupling. This 
makes the method ideal for an evaluation of 3JN~ couplings for all 
residues (except glycine) when overlap or line width makes use of the 
conventional methods difficult. 
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Table 1 (A) 
~H Resonance assignments for the V3 Consensus peptide in water at pH = 2.5 and T = 275 K 
Residue Chemical shift (ppm) 
NH C~H C~H CrH C~H Others 
Cys I 4.48 3.37, 3.14 
Thr 2 9.11 4.44 4.13 1.23 
Arg 3 8.79 4.63 1.86, 1.76 1.70 3.21 7.31 (N'H) 
Pro 4 4.41 2.29, 1.91 2.02 3.84, 3.65 
Asn 5 8.75 4.68 2.85, 2.81 7.79, 7.08 ~ (Nail2) 
Asn 6 8.67 4.73 2.87, 2.79 7.79, 7.07" (N~H2) 
Asn 7 8.65 4.77 2.89, 2.81 7.75, 7.06 (N6H2) 
Thr ~ 8.26 4.31 4.28 1.22 
Arg 9 8.47 4.33 1.86, 1.79 1.65, 1.63 3.19 7.26 (N'H) 
Lys l° 8.50 4.34 1.84, 1.76 1.47, 1.42 1.68 2.99 (C~H2), 7.64 (NCH3) 
Ser tj 8.47 4.47 3.83 
Ile 12 8.33 4.19 1.82 1.34, 1.13 0.83 0.85 (C~'H3) 
His 13 8.77 4.73 3.18, 3.10 7.23 8.57 (C~H) 
Ile 14 8.44 4.23 1.82 1.45, 1.14 0.83 0.91 (CrH3) 
GIyI~ 8.54 4.12 
Pro 4.47 2.28, 1.99" 2.03 3.67, 3.64 
Gly t7 8.72 3.97 
Arg 18 8.30 4.26 1.80, 1.70 1.57 3.15 7.23 (N~H) 
Ala 19 8.43 4.24 1.25 
Phe 2° 8.26 4.56 2.99 7.29 7.12 (C~H2), 7.29 (C¢H) 
Tyr 21 8.26 4.68 3.03, 2.89 7.08 6.78 (C'H:) 
Thr 22 8.20 4.43 4.25 1.21 
Thr 23 8.35 4.29 4.24 1.25 
G l f  4 8.64 4.01, 3.92 
Glu 25 8.23 4.33 2.04, 2.02 2.43 
Ile 26 8.47 4.15 1.86 1.50, 1.16 0.85" 0.87" (CrH0 
Ile 27 8.48 4.10 1.84 1.50, 1.17 0.84 0.91 (CrH3) 
G l f  8 8.63 3.95 
As -~9 8.41 4.73 2.93, 2.84 
lie ~ 8.28 4.15 1.92 1.49, 1.21 0.87 0.91 (CrH3) 
Arg 3t 8.56 4.31 1.84, 1.78 1.67, 1.61 3.20 7.31 (N~H) 
Gin 82 8.44 4.31 2.10, 1.97 2.37 7.68, 7.05 (N~H2) 
Ala 33 8.52 4.27 1.36 
His 34 8.62 4,75 3.30, 3.27 7.35 8.63 (C~H) 
Cys 35 8.66 4,60 3.34, 3.04 
(B) 
~H Resonance assignments for the V3 Consensus peptide in 20% v/v TFE/water solution at T = 280 K 
Residue Chemical shift (ppm) 
N H C~H C~H CrH C~H Others 
Cys t 4.53 3.41, 3.22 
Thr 2 9.03 4.50 4.21 1.29 
Arg 3 8.55 4.70 1.92, 1.78 1.74 3.27 
Pro 4 4.47 2.31, 1.96 2.09 ~, 2.04 ~ 3.85, 3.69 
Asn 5 8.58 4.77 2.93 
Asn 6 8.64 4.71 2.87 
Asn 7 8.63 4.78 2.90 a 
Thr s 8.20 4.32 4.27 1.28 
Arg 9 8.33 4.28 1.93, 1.88 1.74, 1.68 3.24 
Lys m 8.21 4.35 1.91, 1.85 1.54, 1.48 1.73 
Ser H 8.16 4.49 3.91 
lie ~2 7.93 4.18 1.84 1.45, 1.15 0.83" 
His Is 8.48 4.78 3.24, 3.12 7.27 
Ile 14 8.22 4.30 1.87 1.49, 1.17 0.88 a 
GIy:2 8.19 4.12 
Pro 4.48 2.29, 2.04" 2.06 3.71, 3.62 
G l f  v 8.58 4.08, 3.97 
ArgO8 8.21 4.29 1.89, 1.83 1.66 3.22 
AIaE9 8.31 4.29 1.34 
Phe 2° 8.09 4.51 3.08 7.31 
Tyr 21 7.95 4.64 3.13, 2.96 7.12 
Thr 22 8.12 4.40 4.46 1.32 
Thr 23 8.42 4.01 4.21 1.30 
Gly~4 8.34" 3.89, 3.79 
Glu25 7.93 4.15 2.32, 2.18 2.53, 2.42 
Ile 26 8.05 3.83 2.03 1.71, 1.14 0.83 
Ile 27 8.43 3.81 1.91 1.72, 1.24 0.85 
G l f  8 8.16" 3.93 ~, 3.83 a 
As~ 29 8.16 4.59 3.20, 2.90 
Ile- 8.48 3.83 2.05 1.85, 1.16 ~ 0.86 
Arg3t 2 8.60 4.15 1.99, 1.96 a 1.93 ", 1.69 3.19 
Gin 3 8.04 4.30 2.24, 2.21 2.55, 2.48 
Ala ss 7.96 4.31 1.49 
His 34 8.20 4.74 3.46, 3.29 7.43 
Cys 35 8.35 4.64 3.41, 3.17 
7.35 (N'H) 
7.79, 7.03 (NaH2) 
7.75, 7.01 (Nail2) 
7.72, 7.00 (N6H2) 
7.29 (N'H) 
3.03 (C'H2), 7.70 (N¢H3) 
0.86 (CrH3) 
8.59 (C'H) 
0.94 (CrH:0 
7.27 (N'HI 
7.12 (C'H2), 7.31 (CCH) 
6.84 (C'H2) 
0.95 (CrH3) 
0.93 (CrH3) 
0.95 (CrH3) 
7.24 (N'H) 
7.51, 6.91 (N~H2) 
8.61 (C'H) 
"Chemical shift value could not be accurately measured because of overlap. 
120 W.E Vranken et al./FEBS Letters 374 (1995) 117~121 
Aft 0.40 
(ppm) 0 30 
0,20 
0,10 
0.00 
-010 
-020 
-0.30 
-0.40 
i I i I I l l l I l  
I~[ l l l [ l l  
. l | l l l l l l l  
!tlll,r_l1211. 
"U~ ~ 
J [ l l l l l  
I [ l l l l r  
?i 
I I I I I 
I[111 
_Ill[ 
'l|hl.Jl 
I"PIIPi 
I I l [ l l l l l  
I l l l l l l l l  
! . l l l l l l l l  
I[Ikl[l°lllll[ 
! I I1111111111t1' 
I Ill II 'l If II'l 
I Ill I Illll I 
[ III I I'lll I 
li~lu , ,, 
[ [  
II[i 
~ z z z ~ = ~ = ~ K ~ N ~ ~  
Fig. 3. Diagram showing the deviation (Ad = dobs - d~.~.) from random 
coil (r.c.) values of the chemical shift (~ of the ~ protons of the Con- 
sensus V3 loop peptide in water (~) and in a 20% v/v TFE/water 
solution (I). 
(~p,~) space. Without the presence of other helix-indicating 
NOEs, this state is often referred to as a nascent helix [38]. In 
the C-terminal region, however, evidence for a strong tendency 
toward helical structure is present in terms of an Ile26-Asp 29 
d~N(i,i+3) and an Ile3°-Ala 33 dae(i,i+3) NOE contact 
(Fig. 1A). Also, the vicinal JN~ coupling constant for Thr 23 is 
lower than 6.0 Hz in water. 
Experimental NMR evidence from previous tudies on the 
complete V3 loops of the MN [23,24], the Chang Mai [25] and 
the RF (Vranken et al., submitted) strains, and on linear partial 
V3 loop peptides from the IIIB [39] and the RF [40] strains, as 
well as X-ray structures of complexes between antibodies and 
a peptide corresponding to the central region of the V3 loop of 
the MN strain [41,42] revealed the presence of a tight turn in 
the conserved GPGR region. The observed NOE contacts for 
the Consensus V3 loop peptide support this conclusion. Ac- 
cording to our MNR data, both a type I or a type II fl-turn 
conformation are possible for the central region of the Consen- 
sus peptide: the relatively strong Gly~7-Arg ~8 dNN(i,i+ 1) NOE 
and Pro]6-Arg 18 d~N(i,i + 2) NOE are common features of both 
turns, while additional NOE contacts between the Gly t7 NH 
proton and both ,~ protons of Pro 16 and the ~ proton of Gly ~5 
suggest a significant population of a type I fl-turn. The strong 
ProJ6-Gly j7 d~N(i,i+ I) NOE, however, indicates that a type II 
fl-turn can also be present. Contacts involving side chain pro- 
tons from Ile ~2 and Ile]4to Tyr 2j (data not shown) imply that the 
region encompassing the turn forms a relatively structured 
loop. 
The separate Pro4-Asn 6d~N(i,i+ 2) combined with a strong 
Pro4-Asn 5 d~N(i,i+ 1) NOE indicates the presence of another 
fl-turn at this position. The Asn 6 residue is a known glycosyla- 
tion site [10], and theft-turn is possibly important to expose this 
residue for glycosylation [24]. 
3.3. Conformation in the 20% TFE/water solution 
Upon addition of TFE a regular c~-helix is formed in the 
C-terminal part of the peptide. Various NOE contacts indica- 
tive of helix formation (a group of d~N(i,i+2), dNN(i,i+2), 
d~N(i,i + 3), d~p(i,i + 3) NOEs and two d~N(i,i + 4) 
NOEs) are observed from Gly ~7 to His 34 (Fig. 1B). The JN~ 
vicinal coupling constants for the residues in the Thr23-Arg 3~ 
region, as measured by two CT-NOE spectra, have shifted from 
above 6.0 Hz in water to below 6.0 Hz in the 20% TFE solution 
(Fig. 2B). This change is also indicative of helix formation. 
Finally, the ~ protons from Thr 23 to Arg 3~ (except Gly 2s) have 
chemical shift values in 20% TFE which are over 0.1 ppm lower 
than the corresponding random coil values [37] (Fig. 3). Since 
intrinsic changes in chemical shifts of ~ protons as a function 
of TFE concentration i random coil peptides are negligible 
[37], these upfield shifts are consistent with the formation of a 
helical fragment [43]. Overall, the data gathered from these 
three different sources trongly supports the actual presence of 
a helix from at least Thr 23 to Arg 31. 
4. Discussion 
In water solution the main part of the peptide adopts a broad 
range of conformations and is mainly random coil. Some struc- 
tural features nonetheless eem to be present: two fl-turns (one 
at the glycosylation site, one at the conserved central GPGR 
part), and a strong tendency toward helical conformations in
the C-terminal part. In a 20% TFE solution, the C-terminal 
Thr23-Arg 3~ part is predominantly helical. The fl-turn at the 
glycosylation site seems undisturbed upon addition of TFE, but 
conformational changes at the central fl-turn cannot be ex- 
cluded in view of the appearance of Gly ILPhe 2° and Arg18-Tyr 2~ 
d~(i,i + 3) NOEs and a GlylT-Phe 2° d~N(i,i + 3) NOE. 
This V3 Consensus peptide seems, out of all previously stud- 
ies complete V3 loop peptides in TFE/water solution, to have 
the strongest tendency for formation of an a-helix in the C- 
terminal part. The V3 MN peptide showed an almost similar 
helical preference (less helix indicating NOEs were observed), 
but was studied in 30% TFE [24]. The V3 RF peptide in 20% 
TFE (Vranken et al., submitted) also adopts C-terminal c~- 
helical conformations, but helix formation is not as pronounced 
as in the V3 Consensus peptide. 
The appearance of a C-terminal helix from nascent helix (in 
water) when the polarity of the environment decreases (in TFE/ 
water) emerges as a common feature for apparently most HIV- 
1 strains. The C-terminal helices of these studied V3 loop pep- 
tides are amphipathic (Vranken et al., submitted), and this 
suggests that they are to interact favorably with biological in- 
terfaces. It is well known that the V3 loop is actively involved 
in infection [13], and it has been suggested that cleavage of the 
V3 loop between (for Consensus) Arg Is and Ala ~9 is an essential 
step in this process [44,45]. Proximity of the cellular membrane 
after CD4-gpl20 binding could assist he formation of an am- 
phipathic C-terminal a-helix in the V3 loop, and since amphipa- 
thic helices C-terminal to an 'active site' can enhance binding 
of the active site to a receptor [46], the helix formation could 
improve the presentation of the cleavage site to a cell surface 
protease, thereby assisting infection. Alternatively, this C-ter- 
minal amphipathic helix might, after cleavage of the V3 loop, 
cooperate with fusogenic domains of gpl20 and/or gp41 and 
thus help to fuse the membranes of host and virus. The major 
determinant of viral tropism seems to be situated in the C- 
terminal part of the V3 loop [22], and viral tropism also corre- 
lates strongly with side chain electric harges at other specific 
positions in the C-terminal part of the V3 loop [18]. Since both 
T-cell tropic strains (MN and RF) and the macrophagetropic 
Consensus strain show C-terminal helicity in NMR studies, this 
feature seems not to be a major determinant of viral tropism. 
It rather appears that mutations in both classes preserve the 
helical tendency. However, the positioning of the charged resi- 
dues on a C-terminal helix, combined with the influence of helix 
formation on the structure of the rest of the V3 loop, might well 
be important in determining interactions of the V3 loop with 
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host proteins. Improved characterizations of the three-dimen- 
sional structures of entire V3 loops are required to accurately 
interprete the data on viral tropism. Such attempts are pres- 
ently in progress in this laboratory. 
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